Skip to main content
. Author manuscript; available in PMC: 2011 May 1.
Published in final edited form as: Mech Ageing Dev. 2010 Apr 24;131(5):338ā€“345. doi: 10.1016/j.mad.2010.04.001

Figure 2.

Figure 2

Probability of staying free of (A) cancer and (B) compound phenotype of myocardial infarction (MI) and intermittent claudication (IC) for (A) men and women and (B) men carrying compound genotypes of the ADRB2 Arg16Gly and Gln27Glu polymorphisms (patterns of probability are ordered according to increasing relative risks; see insets). Protective Gly16Glu27 haplotype is italicized and underlined (given that the Arg16Glu27 haplotype is virtually lacking, see Table 1, haplotypes are uniquely determined from the respective genotypes). The letter ā€œNā€ in the inset denotes sample size with non-missing information on all covariates. The numbers in parentheses are counts of individuals with onsets of respective condition within the follow-up period (months). The RR (CI) denotes relative risks (confidence intervals) calculated using the Cox regression model adjusted for age, sex (when necessary), systolic and diastolic blood pressures, total and high density lipoprotein cholesterol, body mass index, smoking, and diabetes. *0.01<p<=0.05; **p<=0.01.